Intracellular targeting of proteins by sumoylation

Experimental Cell Research

Volumn 271, Issue 1, 2001, Pages 57-65

  Wilson, Van G ^a   Rangasamy, Dhandapani ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; UBIQUITIN;

CELL NUCLEUS INCLUSION BODY; CELLULAR DISTRIBUTION; CONJUGATION; COVALENT BOND; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN TARGETING; SHORT SURVEY; SUMOYLATION;

EID: 0035890322     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2001.5366     Document Type: Article

References (62)

1. Modes of regulation of ubiquitin-mediated protein degradation
2. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia
3. Ubl1, a human ubiquitin-like protein associating with human rad51/rad52 proteins
4. Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin
5. Evidence that the MIF2 gene of Saccharomyces cerevisiae encodes a centromere protein with homology to the mammalian centromere protein CENP-C
6. The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer
7. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex
8. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2
9. Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association
10. Ubch9 conjugates SUMO but not ubiquitin
11. Evolution and function of ubiquitin-like protein-conjugation systems
12. Ubiquitin-like proteins: New wines in new bottles
13. SUMO - Nonclassical ubiquitin
14. SUMO/sentrin: Protein modifiers regulating important cellular functions
15. SUMO, ubiquitin's mysterious cousin
16. Preferential modification of nuclear proteins by a novel ubiquitin-like molecule
17. Structure determination of the small ubiquitin-related modifier SUMO-1
18. SMT3A, a human homologue of the S. cerevisiae SMT3 gene, maps to chromosome 21qter and defines a novel gene family
19. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3
20. Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p
21. Modification of Ran GTPase-activating protein by the small ubiquitin-related modifier SUMO-1 requires Ubc9, an E2-type ubiquitin-conjugating enzyme homologue
22. Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2
23. Cloning, expression, and mapping of UBE21, a novel gene encoding a human homologue of yeast ubiquitin-conjugating enzymes which are critical for regulating the cell cycle
24. mUBC9, a novel adenovirus E1A-interacting protein that complements a yeast cell cycle defect
25. Identification of the structural and functional human homolog of the yeast ubiquitin conjugating enzyme UBC9
26. Crystal structure of murine/human Ubc9 provides insight into the variability of the ubiquitin-conjugating system
27. The binding interface between an E2 (UBC9) and a ubiquitin homologue (UBL1)
28. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1
29. Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex
30. An essential yeast gene encoding a homolog of ubiquitin activating enzyme
31. In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2
32. Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9
33. The ubiquitin system
34. Identification of three major sentrinization sites in PML
35. Covalent modification of the transactivator protein IE2-p86 of humancytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b
36. Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9
37. A new protease required for cell-cycle progression in yeast
38. The yeast ULP2 (SMT4) gene encodes a novel protease specific for the ubiquitin-like Smt3 protein
39. Yeast Ulp1, an Smt3-specific protease, associates with nucleoporins
40. SUMO conjugation and deconjugation
41. A new 30-kDa ubiquitin-related SUMO-1 hydrolase from bovine brain
42. A new SUMO-1-specific protease, SUSP1, that is highly expressed in reproductive organs
43. Differential regulation of sentrinized proteins by a novel sentrin-specific protease
44. A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase
45. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus
46. A functional interaction between dorsal and components of the Smt3 conjugation machinery
47. Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1
48. SUMO-1 modification of bovine papillomavirus E1 proteinis required for intranuclear accumulation
49. SUMO-1 modification activates the transcriptional response of p53
50. c-Jun and p53 activity is modulated by SUMO-1 modification
51. SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex
52. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1
53. The nuclear dot protein Sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers
54. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: Implications for nuclear localisation
55. Role of SUMO-1-modified PML in nuclear body formation
56. PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1
57. Identification of a 68-kilodalton nuclear ATP-binding phosphoprotein encoded by bovine papillomavirus type 1
58. Genetically defined nuclear localization signal sequence of bovine papillomavirus E1 protein is necessary and sufficient for the nuclear localization of E1-beta-galactosidase fusion proteins
59. Bovine papillomavirus E1 protein is sumoylated by the host cell Ubc9 protein
60. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting
61. The Drosophila semushi mutation blocks nuclear import of bicoid during embryogenesis
62. Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies